Celldex Therapeutics CLDX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's asset turnover?
- Celldex Therapeutics (CLDX) reported asset turnover of 0× in Q1 2026.
- How has Celldex Therapeutics's asset turnover changed year-over-year?
- Celldex Therapeutics's asset turnover decreased by 85.1% year-over-year, from 0× to 0×.
- What is the long-term trend for Celldex Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Celldex Therapeutics's asset turnover has grown at a -44.4% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.